Related by context. All words. (Click for frequent words.) 69 budiodarone 67 elotuzumab 67 Bicifadine 67 alvimopan 67 noninferiority 67 RSD# oral 67 cangrelor 67 Mipomersen 67 JAK inhibitor 67 RSD# 67 TNF alpha inhibitor 67 bicifadine 66 lomitapide 66 otelixizumab 66 pharmacodynamic properties 66 tezampanel 66 Fibrin Pad 66 teriflunomide 66 CoFactor 66 muraglitazar 66 phase IIb clinical 66 ancrod 66 HuLuc# 66 fondaparinux 65 regorafenib 65 ASONEP 65 Ereska 65 sorafenib Nexavar 65 atrasentan 65 vidofludimus 65 ELND# 65 Tavocept 65 cilengitide 65 pegylated interferons 65 pain palliation 65 BAY #-# 65 enzastaurin 65 GAMMAGARD 65 SNRI 65 Corlux 65 riociguat 65 ponatinib 65 eprotirome 65 antithrombotic 65 oral anticoagulant 65 active comparator 65 idraparinux 65 oral anticoagulation 65 antiarrhythmic drug 65 DU #b 65 PRT# 65 betrixaban 64 Viprinex 64 edifoligide 64 clevidipine 64 pharmacokinetic equivalence 64 Amplimexon 64 Neuradiab 64 xanthine oxidase inhibitor 64 cediranib 64 Epanova 64 aflibercept 64 pradefovir 64 uric acid lowering 64 Plicera 64 subcutaneously administered 64 platelet inhibitor 64 deforolimus 64 Vernakalant 64 TOLAMBA 64 faropenem 64 antiplatelet agent 64 REG1 64 dosage regimens 64 ProSavin 64 taribavirin 64 SCH # 64 posaconazole 64 tocilizumab 64 ganetespib 64 ADAGIO study 64 Neurodex 64 antithrombotics 64 Panzem R NCD 64 dirucotide 64 Dasatinib 64 EVIZON 64 Asentar 64 reslizumab 64 oxymorphone ER 64 Firazyr 64 Zoraxel 64 Targretin 64 Factor Xa inhibitor 64 pertuzumab 64 MAGE A3 ASCI 64 lapatinib Tykerb 64 EmbraceAC 64 Allovectin 7 ® 64 Traficet EN 64 CBLC# 64 EOquin TM 64 ACTEMRA TM 64 OncoVEX GM CSF 64 decitabine 64 visilizumab 64 antiarrhythmic 64 PDE4 inhibitor 63 diabetic neuropathic pain 63 IV bisphosphonates 63 oral rivaroxaban 63 vemurafenib 63 valopicitabine 63 anti arrhythmic 63 Rivaroxaban 63 ustekinumab 63 anidulafungin 63 INTEGRILIN 63 NGX# 63 Phenoptin 63 ularitide 63 ARIKACE ™ 63 Desmoteplase 63 apremilast 63 oral ridaforolimus 63 CCX# 63 Alfimeprase 63 rhThrombin 63 RhuDex ® 63 bezafibrate 63 carotid artery stenting 63 OvaRex ® MAb 63 ZOLINZA 63 XmAb# 63 Orazol 63 EDEMA3 63 PSN# [001] 63 torezolid phosphate 63 cannabinor 63 Zerenex 63 Ophena TM 63 Zemplar Capsules 63 efficacy endpoint 63 midstage clinical 63 dexanabinol 63 baminercept 63 AEGR 63 liposomal formulation 63 TOCOSOL Paclitaxel 63 Tyrima 63 LCP AtorFen 63 T Pred 63 darapladib 63 Tamibarotene 63 Perforomist ™ Inhalation Solution 63 novel oral anticoagulant 63 GSK# [002] 63 PRIMO CABG 63 Tarceva TM 63 Q#IR 63 systemic immunosuppressive drugs 63 anti angiogenic agents 63 cobiprostone 63 Genz # 63 tipranavir 63 phase IIa clinical 63 orBec 63 pharmacodynamics PD 63 pharmacokinetic profiles 63 Xinlay 63 Deforolimus 63 L BLP# 63 APTIVUS 63 maximally tolerated dose 63 phase IIb 63 CIMZIA ™ 63 Viramidine 63 amrubicin 63 TNF inhibitor 63 MyVax personalized immunotherapy 63 DAPT 63 obatoclax 63 CDP# 63 nalbuphine ER 63 Zybrestat 63 Vilazodone 63 Noxafil 63 NV1FGF 63 AZILECT R 63 ISTODAX 63 bioequivalency 63 edoxaban 63 bendamustine 63 PDE4 inhibitors 62 FTY# 62 indibulin 62 Octreolin 62 SILENOR 62 Phase #b/#a 62 vosaroxin 62 SERMs 62 PFO migraine 62 vicriviroc 62 galiximab 62 factor Xa inhibitor 62 glatiramer acetate 62 serum phosphorus 62 INT# [002] 62 eniluracil 62 Phase Ib study 62 metastatic HRPC 62 oral antidiabetic 62 ARCOXIA 62 Study GL# 62 Icatibant 62 Protelos 62 GRN# 62 cognitive enhancer 62 Velcade bortezomib 62 axitinib 62 PREOS 62 dexpramipexole 62 lumiliximab 62 NEVO ™ 62 KRN# 62 surrogate endpoint 62 canakinumab 62 alfimeprase 62 pomalidomide 62 Fodosine 62 DXL# 62 abacavir lamivudine 62 intensive lipid lowering 62 ridaforolimus 62 Amrubicin 62 INCB# [001] 62 atacicept 62 forodesine 62 Relovair 62 SinuNase 62 tenofovir emtricitabine 62 angiographic outcomes 62 eptifibatide 62 rNAPc2 62 noninfectious uveitis 62 non inferiority 62 methylnaltrexone 62 erlotinib Tarceva 62 bifeprunox 62 ALGRX 62 confirmatory clinical 62 briakinumab 62 confirmatory Phase III 62 Dabigatran 62 tanespimycin 62 Vascular Wrap 62 mycophenolate mofetil 62 Civacir 62 PREZISTA r 62 oral talactoferrin 62 lurasidone 62 viral kinetics 62 efficacy tolerability 62 Phase #b/#a trial 62 Combo Stent 62 MAP# 62 NOXAFIL 62 febuxostat 62 HZT 62 lasofoxifene 62 octreotide LAR 62 custirsen 62 Pharmacokinetic studies 62 metaglidasen 62 mTOR inhibitors 62 lanthanum carbonate 62 oral prodrug 62 teduglutide 62 iSONEP 62 YONDELIS 62 GSK# [001] 62 dosage regimen 62 MERLIN TIMI 62 sipuleucel T 62 oxaliplatin Eloxatin 62 iniparib 62 rEV# 62 Novartis Zometa 62 EndoTAG TM -1 62 eltrombopag 62 Aclidinium 62 preclinically 62 brivaracetam 62 placebo controlled clinical 62 docetaxel Taxotere ® 62 vernakalant 62 schizophrenia CIAS 62 capsule formulation 62 Onconase 62 Synavive 62 antidiabetic agents 62 Acapodene 62 pharmacokinetics PK 62 Dabigatran etexilate 62 favorable pharmacokinetic profile 62 doxorubicin docetaxel 62 varespladib 62 AZILECT ® 62 ZD# [001] 62 CB1 antagonists 62 mapatumumab 62 Virulizin ® 62 peginesatide 62 RE LY 62 Fibrillex 62 palonosetron 62 Amigal 62 antiplatelet 62 NeuroSTAT ® 62 DexaSite 62 postoperative ileus 62 ximelagatran 62 synthetic retinoid 62 Diovan HCT 62 PD LID 62 carvedilol 62 liprotamase 62 mTOR inhibitor 62 analgesic efficacy 62 tasocitinib 62 Medidur FA 62 ZYBRESTAT 62 danoprevir 62 Golimumab 61 Allovectin 7 61 dalbavancin 61 generic gabapentin 61 oxybutynin gel 61 Symadex 61 Phase 1b trial 61 pegylated IFN 61 INVEGA ® 61 viral kinetic 61 PRADAXA 61 Clolar ® 61 Afresa 61 Phase IIIb clinical 61 Muraglitazar 61 calcineurin inhibitors 61 ibudilast 61 Tekamlo 61 insulin sensitizing 61 CIMZIA TM 61 proteasome inhibitor 61 anti TNFs 61 AzaSite Plus 61 antiangiogenic therapy 61 temsirolimus 61 Archexin 61 EDEMA3 trial 61 GFT# 61 anticlotting drugs 61 biologic therapy 61 CR# vcMMAE 61 ocrelizumab 61 thienopyridines 61 Xanafide 61 adipiplon 61 RLY# 61 Starlix 61 Azedra 61 volociximab 61 radezolid 61 MEVACOR 61 Bezielle 61 everolimus eluting stents 61 ruxolitinib 61 ULORIC 61 thalidomide Thalomid 61 nonrandomized 61 CG# [003] 61 CINQUIL 61 elagolix 61 atypical antipsychotic 61 TriRima 61 APTIVUS r 61 Combination therapy 61 sunitinib 61 platelet inhibition 61 successfully commercialize Iluvien 61 zoledronic acid Zometa 61 cystinosis patients 61 TORISEL 61 mRCC 61 Zevalin consolidation 61 KNS # 61 Betaferon ® 61 thrombolytic agents 61 secondary efficacy endpoints 61 Vectibix panitumumab 61 AGHD 61 cilostazol 61 fosbretabulin 61 class mGluR5 inhibitor 61 Targretin capsules 61 eluting stent 61 maximally tolerated 61 DCCR 61 CA4P 61 Rebif ® 61 fidaxomicin 61 metformin sulfonylurea 61 ospemifene 61 CYPHER R Sirolimus eluting 61 bucindolol 61 NATRECOR R 61 Cethromycin 61 radiation sensitizer 61 topical calcineurin inhibitors 61 Relivar 61 Crestor rosuvastatin 61 dacetuzumab 61 Degarelix 61 pharmacokinetic characteristics 61 daclizumab 61 telcagepant 61 pazopanib 61 CYT# QbG# 61 ranolazine 61 beta interferons 61 canagliflozin 61 zalutumumab 61 LHRH antagonists 61 Revimmune 61 fulvestrant 61 phase IIb trial 61 Phase 2b study 61 bicalutamide 61 lipid lowering therapies 61 OvaRex R 61 panitumumab 61 Clonicel 61 Cinquil 61 carotid stenting 61 Votrient 61 docetaxel Taxotere R 61 pharmacodynamic effects 61 BRAF inhibitor 61 OncoVEX 61 predialysis 61 M6G 61 TACI Ig 61 angiotensin receptor blocker ARB 61 safinamide 61 MoxDuo 61 TBC# 61 clopidogrel Plavix 61 pexelizumab 61 tesmilifene 61 HAART regimens 61 peginterferon 61 optimal dosing regimens 61 oral salmon calcitonin 61 Itopride 61 antitumor effect 61 HuMax CD4 61 PFO closure 61 Durezol 61 CTAP# Capsules 61 PROMACTA 61 MIRCERA 61 LY# [003] 61 NATRECOR ® 61 Technosphere Insulin 61 NP2 Enkephalin 61 Actimmune ® 61 latanoprost 61 lipid lowering therapy 61 Integrilin 61 Apixaban 61 MoxDuo TM IR 61 adecatumumab 61 EGS# 61 MabCampath 61 FOSRENOL R 61 dabigatran etexilate 61 BAL# [002] 61 docetaxel chemotherapy 61 Combidex 61 pharmacokinetic PK profile 61 FOSRENOL ® 61 ARB telmisartan 61 EXPAREL 61 Pemetrexed 61 BrachySil 61 zotarolimus 61 systemically administered 61 Stedivaze 61 6R BH4 61 fenofibric acid 61 sirolimus 61 Capesaris 61 LymphoStat B 61 Torisel 61 bevacizumab Avastin ® 61 rindopepimut 61 perampanel 61 Tolamba 61 Dextofisopam 61 nitazoxanide 61 tapentadol ER 61 virus HCV protease inhibitor 61 romiplostim 61 daptomycin 61 Phase #/#a 61 HIF PH inhibitors 61 lipid lowering 60 phase IIb study 60 PSN# [002] 60 INVEGA ™ 60 almorexant 60 CANCIDAS 60 VAPRISOL 60 investigational therapies 60 casopitant 60 MK #A [001] 60 RoACTEMRA 60 boosted protease inhibitor 60 Androxal TM 60 DPP4 60 Numax 60 aleglitazar 60 TYGACIL 60 elacytarabine 60 SILENOR ™ 60 irbesartan 60 sargramostim 60 MYDICAR ® 60 HGS# 60 HyQ 60 inhaled formulation 60 lenalidomide Revlimid 60 AIM HIGH 60 antifibrotic 60 abatacept 60 bazedoxifene 60 fenretinide 60 Cloretazine 60 Elvitegravir 60 leukotriene receptor antagonists 60 VADT 60 MICARDIS ® 60 glycated hemoglobin levels 60 TNF alpha inhibitors 60 ATL# [001] 60 pioglitazone Actos 60 ceftaroline 60 PITX2 methylation 60 prospective multicenter randomized 60 antihypertensive agents 60 RE LY ® 60 SPRIX ® 60 oral anticoagulants 60 Endeavor DES 60 MGN# 60 Onrigin 60 TLK# 60 RIGScan CR 60 ranibizumab Lucentis 60 ticagrelor 60 dose regimens 60 sorafenib Nexavar ® 60 donepezil Aricept 60 lipid lowering agents 60 rilonacept 60 TKM ApoB 60 galantamine 60 CINTREDEKIN BESUDOTOX 60 ACCORD Lipid 60 bardoxolone 60 antidiabetic drugs 60 injectable formulations 60 Aurexis 60 ALVESCO HFA 60 Plasmin 60 LDL lowering 60 direct thrombin inhibitors 60 incyclinide 60 MoxDuo IR 60 levosimendan 60 EOquin 60 LEP ETU 60 Dalbavancin 60 gadobutrol 60 Ticagrelor 60 adenosine injection 60 oral antiplatelet 60 FM VP4 60 IIIa inhibitor 60 ezogabine 60 HuMax CD# 60 MAXY G# 60 Reverset 60 Resten NG 60 PrevOnco 60 Phase IIb clinical trials 60 antidepressant efficacy 60 BCR ABL inhibitor 60 QT prolongation 60 AGILECT R 60 relapsed MM 60 NEBIDO 60 VA# [002] 60 Androxal 60 zolmitriptan 60 VELCADE melphalan 60 glatiramer acetate Copaxone 60 Brinavess 60 tacrolimus ointment 60 delafloxacin 60 ACE inhibitor ramipril 60 rifalazil 60 evaluating tivozanib 60 CYPHER ® Sirolimus eluting 60 serotonin norepinephrine reuptake inhibitor 60 QVAR 60 Valdoxan 60 Frova ® 60 iroxanadine 60 quinolone 60 VEGF inhibitor 60 molecular weight heparins 60 antithrombotic agents 60 CYCLOSET 60 opioid induced bowel dysfunction 60 HQK 60 Vidaza azacitidine 60 ivabradine 60 ONTAK 60 RezularTM 60 bortezomib Velcade 60 MEK inhibitor RDEA# 60 oral methylnaltrexone 60 immunosuppressant therapies 60 Revlimid lenalidomide 60 tezampanel NGX# 60 GP IIb IIIa inhibitor 60 ToGA 60 ruboxistaurin 60 tigecycline 60 Zalbin 60 DP b# 60 desvenlafaxine 60 SGS# 60 PhosLo 60 micafungin 60 Spiegelmer ® 60 FIRMAGON R 60 Instanyl 60 QTc prolongation 60 alpha blocker 60 #ME# 60 triglyceride lowering 60 zileuton 60 optimal dosing 60 sirolimus eluting stents 60 #mg doses [002] 60 Gattex 60 ABSORB trial 60 Teriflunomide 60 neuroprotectant 60 OMAPRO 60 ATACAND 60 Femara letrozole 60 EndoTAGTM 1 60 warfarin therapy 60 heparins 60 PXD# 60 Fampridine SR 60 Nuvion 60 zotarolimus eluting stent 60 aspirin clopidogrel 60 rFVIIa 60 glufosfamide 60 rivaroxaban 60 Nebido 60 triphendiol 60 OvaRex 60 anticancer therapies 60 antiresorptive 60 Darusentan 60 Bifeprunox 60 dosing frequency 60 rituximab Rituxan 60 SLx 60 TOCOSOL Camptothecin 60 NSABP C 60 salmeterol fluticasone 60 BENICAR HCT 60 MEND CABG II 60 cardiovascular morbidity 60 fenofibrate 60 peginterferon alfa 2b 60 tolevamer 60 treprostinil 60 Urocidin 60 Folotyn 60 inhibitor RG# 60 STRIDE PD 60 selective modulator 60 LibiGel ® 60 DACH platinum 60 stavudine d4T 60 alvespimycin 60 CaPre TM 60 antithrombotic therapy 60 sitaxsentan 60 desvenlafaxine succinate 60 anti leukemic 60 Candesartan 60 caspofungin 60 mealtime insulin 60 R#/MEM 60 noninferior 60 intravenous dosing 60 palifosfamide 60 sorafenib tablets 60 double blinded placebo 60 GP IIb IIIa inhibitors 60 Certican 60 unfractionated heparin 60 NovoTTF 60 adalimumab 60 IV APAP 60 AZOR 60 efficacy endpoints 60 Fampridine 60 DR Cysteamine 60 macrolide antibiotics 60 GED aPC 60 paclitaxel Taxol ® 60 CRx 60 bivalirudin 60 AEG# 60 rolofylline 60 Pertuzumab 60 Ambrisentan 60 Cethrin 60 SILENOR TM 60 factor Xa inhibitors 60 AMEVIVE 60 anticoagulant warfarin 60 olaparib 60 #mg dose [001] 60 TG# [003] 60 interferon therapy 60 #mg dose [002] 60 subgroup analyzes 60 celgosivir 60 fostamatinib 60 Cancidas 60 TPI ASM8 60 DepoDur TM 60 Anturol TM 60 antiplatelet drugs 60 achieved statistical significance 60 Erbitux cetuximab 60 angiographic restenosis 60 cladribine 60 PS# [001] 60 clinical endpoints 60 vascular disrupting agent 60 PHX# 60 registrational 60 therapeutic regimens 60 Intravail R 60 goserelin 60 topotecan 60 vildagliptin 60 Phase Ib 60 Nasulin 60 Toremifene 60 Rasilez Tekturna 60 tasimelteon 60 dacarbazine 60 lintuzumab 60 alefacept 59 Multaq R 59 Afatinib 59 phosphate binder 59 interferon beta 1b 59 Nexavar sorafenib 59 sapacitabine 59 CETP inhibition 59 FROVA 59 paclitaxel eluting stent 59 Cleviprex TM clevidipine 59 CA9 SCAN 59 insulin sensitizers 59 ISIS # 59 MiStent DES 59 Temsirolimus 59 velafermin 59 Non inferiority 59 Aptivus ® 59 dopamine partial agonist 59 generation purine nucleoside 59 Certriad 59 azacitidine 59 Pruvel 59 Aflibercept 59 MGCD# [001] 59 reboxetine 59 MGd 59 PDE# inhibitors 59 budesonide foam 59 corticosteroid dexamethasone 59 Fibrillex TM 59 Dyloject TM 59 cardiac toxicity 59 somatostatin analogues 59 FACTIVE tablets 59 therapeutic equivalence 59 Horizant 59 certolizumab 59 pharmacodynamic profile 59 OHR/AVR# 59 randomized Phase 2b 59 Ketotransdel 59 INTELENCE 59 Solulin 59 Altastaph 59 ritonavir boosted 59 dose cohorts 59 QVA# 59 secondary efficacy endpoint 59 Pirfenidone 59 tolerability profiles 59 dose cohort 59 MyVax 59 TELINTRA 59 CIMZIA TM certolizumab pegol 59 Flutiform TM 59 IRX 2 59 endoscopic gastric ulcers 59 complete cytogenetic response 59 FASLODEX 59 MBP# [001] 59 Erlotinib 59 cortical stimulation 59 Glypromate 59 Anidulafungin 59 SARMs 59 INTEGRILIN ® 59 intravenous cyclophosphamide 59 cinacalcet 59 protease inhibitor PI 59 pharmacodynamic profiles 59 HCV protease inhibitors 59 vascular disrupting agents 59 IL# PE#QQR 59 clinically meaningful efficacy 59 desmoteplase 59 Laquinimod 59 Evoltra ® 59 GLP1 agonist 59 ixabepilone 59 peg interferon 59 AERx iDMS 59 Panzem R 59 TELCYTA 59 LAF# 59 tremelimumab 59 doripenem 59 SinuNase TM 59 recurrent VTE 59 romidepsin 59 phosphate binders 59 dosing regimens 59 Arcalyst 59 TREDAPTIVE 59 SIMCOR 59 Rasagiline 59 Prosaptide 59 maximal doses 59 Edwards SAPIEN valve 59 Iloperidone 59 CRMD# 59 dose proportionality 59 urocortin 2 59 NRTI 59 Pennsaid R 59 dose escalation Phase 59 PROVIGIL 59 Focalin XR 59 PEG Interferon lambda 59 LMWH 59 tolerability profile 59 Exforge HCT 59 Arixtra 59 CIMZIA R 59 Doribax 59 ReN# 59 Omigard 59 TAXUS Liberte Stent 59 Octreotide 59 epigenetic therapies 59 DORIBAX 59 ostarine 59 HuMax EGFr 59 oxcarbazepine 59 LATUDA 59 Prestara 59 rilpivirine 59 TRIOLEX 59 DIFICID 59 SUTENT ® 59 phase Ib 59 Lixivaptan 59 plasma kallikrein inhibitor 59 NVA# 59 chemopreventive agent 59 Visipaque 59 davunetide intranasal AL 59 fibrate 59 FOLFOX6 chemotherapy regimen 59 COMT inhibitors 59 enoximone 59 relapsed multiple myeloma 59 Emselex 59 invasive candidiasis 59 Ranexa 59 samalizumab 59 drug eluting coronary stents 59 Telmisartan 59 pharmacodynamic parameters 59 MDV# 59 Zenvia ™ 59 Nanobody ® 59 inhaled iloprost 59 IGF 1R inhibitor 59 pegaptanib 59 Naproxcinod 59 dronedarone 59 Viprinex TM 59 ThGRF 59 lumiracoxib 59 gefitinib Iressa 59 Panitumumab 59 UPLYSO 59 iclaprim 59 Panzem 59 HCl capsules 59 amphotericin B 59 CorVue ™ 59 Pixuvri 59 Onbrez Breezhaler 59 Treanda 59 renal toxicity 59 biphasic insulin aspart 59 BEMA TM Fentanyl 59 Kaletra lopinavir ritonavir 59 mipomersen 59 motesanib 59 CTA# 59 IOP lowering 59 Daclizumab 59 active moiety 59 Egrifta 59 Aliskiren 59 Inhalation Solution 59 Stelara 59 paclitaxel eluting stents 59 alteplase 59 Argatroban 59 valsartan 59 genotypic resistance 59 aclidinium 59 serum phosphorous 59 ATL# [002] 59 BrachySil TM 59 prospective randomized placebo 59 refractory CLL 59 MYDICAR 59 Omapro 59 XGEVA 59 sulphonylureas 59 EP #R 59 MEK inhibitors 59 anacetrapib 59 vismodegib 59 Omacetaxine 59 GLP toxicology studies 59 interferon alfa 2b 59 JAK inhibitors 59 aflibercept VEGF Trap 59 Trizytek 59 GLPG# 59 heterozygous FH